Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR MYOTONIC DYSTROPHY (EFFECTIVE 07/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR ALZHEIMER’S DISEASE (EFFECTIVE 07/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - MALIGNANT GLIOMAS INCLUDING MGMT PROMOTER METHYLATION | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC RESONANCE ANGIOGRAPHY AND MAGNETIC RESONANCE VENOGRAPHY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RECONSTRUCTIVE BREAST SURGERY AND MANAGEMENT OF BREAST IMPLANTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | METHOTREXATE (MTX) POLYGLUTAMATE TESTING TO MEASURE RESPONSE TO METHOTREXATE THERAPY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVENOUS IMMUNE GLOBULIN (IVIG) FOR RECURRENT EARLY PREGNANCY LOSS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CARDIAC HEMODYNAMIC MONITORING FOR THE MANAGEMENT OF HEART FAILURE IN THE OUTPATIENT SETTING | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CERLIPONASE ALFA: BRINEURA (J0567) RETIRED AS OF 10/8/2020 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROPROCESSOR-CONTROLLED PROSTHESES AND ORTHOSES FOR THE LOWER LIMB - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DIGITAL BREAST TOMOSYNTHESIS (3-D MAMMOGRAPHY) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | THERAPEUTIC LIGHT BOX FOR THE TREATMENT OF MAJOR DEPRESSION WITH SEASONAL PATTERN | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ORTHOPTIC TRAINING/VISION THERAPY FOR THE TREATMENT OF VISION OR LEARNING DISABILITIES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATIC URETHRAL LIFT PROCEDURE FOR THE TREATMENT OF BPH - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LOW-DOSE RADIOFREQUENCY FOR NASAL VALVE REMODELING - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CRYOSURGICAL ABLATION OF PRIMARY OR METASTATIC LIVER TUMORS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYOELECTRIC PROSTHETIC AND ORTHOTIC COMPONENTS FOR THE UPPER LIMB - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - JAK2, MPL AND CALR TESTING FOR MYELOPROLIFERATIVE NEOPLASMS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GALECTIN-3 TESTING IN THE ASSESSMENT AND MANAGEMENT OF CHRONIC HEART FAILURE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TIBIAL NERVE STIMULATION FOR URINARY AND FECAL INCONTINENCE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LABORATORY TESTS - GENETIC, MOLECULAR AND OTHER- EXPERIMENTAL/INVESTIGATIONAL STATUS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATIC ARTERY EMBOLIZATION (PAE) FOR BENIGN PROSTATIC HYPERTROPHY (BPH) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PNEUMOCOCCAL CONJUGATE VACCINE, 21 VALENT (PCV21), FOR INTRAMUSCULAR USE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BEQVEZ (FIDANACOGENE ELAPARVOVEC-DZKT) ***RETIRED AS OF 12/4/2025*** | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MARQIBO (VINCRISTINE SULFATE LIPOSOME) (RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT) OF THE PROSTATE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INFUSION OF THERAPEUTIC AGENTS TO THE BRAIN (CONVECTION-ENHANCED INTRAPARENCHYMAL DELIVERY) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SATURATION BIOPSY FOR DIAGNOSIS AND STAGING OF PROSTATE CANCER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSTYMPANIC MICROPRESSURE APPLICATIONS AS A TREATMENT OF MÉNIÈRE’S DISEASE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - CABAZITAXEL: JEVTANA (J9043) RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LIGHT AND LASER THERAPY FOR VITILIGO AND ATOPIC DERMATITIS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PHRENIC NERVE STIMULATION FOR CENTRAL SLEEP APNEA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCBSM ONLY: 48-HOUR LIMITATION OF OBSERVATION BED SERVICES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC CANCER SUSCEPTIBILITY PANELS USING NEXT GENERATION SEQUENCING | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NEAR-INFRARED SPECTROSCOPY-INTRAVASCULAR CORONARY IMAGING - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSITRON EMISSION TOMOGRAPHY (PET) FOR ONCOLOGIC CONDITIONS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ALTERNATIVE PHYSICAL THERAPY MODALITIES-EXPERIMENTAL/INVESTIGATIONAL - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYOLYSIS OF UTERINE FIBROIDS USING LAPAROSCOPIC, PERCUTANEOUS OR TRANSCERVICAL TECHNIQUES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR SELECT INTRA ABDOMINAL AND PELVIC MALIGNANCIES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CLOSURE DEVICES FOR PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OPTICAL COHERENCE TOMOGRAPHY IMAGING, ANTERIOR EYE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - BLINATUMOMAB: BLINCYTO (J9039) (RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR ALPHA-1 ANTITRYPSIN DEFICIENCY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SEROLOGIC GENETIC AND MOLECULAR SCREENING FOR COLORECTAL CANCER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INGESTIBLE CAPSULE (E.G., SMARTPILL) FOR ASSESSMENT OF GI MOTILITY DISORDERS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SKIN AND TISSUE SUBSTITUTES INCLUDING AMNIOTIC PRODUCTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOFREQUENCY ABLATION OF MISCELLANEOUS SOLID TUMORS, EXCLUDING LIVER TUMORS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYOCARDIAL SYMPATHETIC INNERVATION IMAGING- HEART FAILURE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | STEM CELL TRANSPLANT FOR SPINAL CORD INJURY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LASER INTERSTITIAL THERMAL THERAPY FOR NEUROLOGICAL CONDITIONS - MEDICARE ADVANTAGE | New policy |